Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent Miscarriage

NCT00722475 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Secondary Recurrent Miscarriage

Interventions

DRUG: Intravenous immunoglobulin
DRUG: Human albumin

Sponsor

Rigshospitalet, Denmark

Collaborators

[object Object]